Aug 12, 2026·Score 76·Type A — Value-style analysisUsed for established, cash-generative companies — weighs earnings power, valuation against the company's own history and peers, and margin of safety.Full methodology →
Current PriceThe market price around the time this report was written — not a live quote. The market has moved since; check a current price before acting.Methodology →$51.42
Buy ZoneThe large figure is the midpoint of the suggested buy range shown in parentheses.$48.00($46.00–$50.00)
Price TargetOur estimated fair value. For richly valued stocks it can sit below the current price — see Methodology.Methodology →$58.01
Expected Return
Target relative to the Current Price ((Target − Current) ÷ Current). Since that price is from the report date, your actual return will differ.
A negative figure isn't an error. For richly valued stocks, the fair-value target can sit below the current price, so the return reads negative. The grade reflects company quality; this figure reflects today's entry valuation.
Type A - Zurn Elkay Water Solutions Corporation (ZWS) 20260812 Stock Analysis
📅 Zurn Elkay Key Upcoming Events
October 28, 2026Q3 2026 Earnings Release (Estimated)
Description: Institutional investors and sell-side analysts will be closely monitoring the initial margin impact and integration progress of the newly closed $109 million acquisition of Intellihot. The market will heavily scrutinize the institutional channel’s core sales momentum to ensure that the 10% organic growth rate achieved in the second quarter was not a cyclical peak but a sustainable trend.
November 05, 2026End date of lock-up agreement for Ice Mountain LLC (Estimated)
Description: The lock-up agreement governing the remaining shares held by Ice Mountain LLC—the holding entity for the founding Katz family of Elkay—is slated to expire in late 2026. Given their previous secondary offering of 8.9 million shares in early 2025, any further liquidation could create a significant technical overhang on the stock, necessitating careful monitoring of insider filing activity.
February 10, 2027Q4 2026 Earnings Release (Estimated)
Description: The market will evaluate the full-year adjusted EBITDA performance against the recently upgraded $503-$513 million guidance framework. Additionally, management has signaled that late 2026 and early 2027 will see the launch of new products in adjacent categories and potentially new acquisitions, making this call a critical catalyst for forward-looking total addressable market (TAM) expansions.
🏢 Step 1: Zurn Elkay Company Overview & Business Model
Q1-A1. What is Zurn Elkay?
Company Name (Ticker): Zurn Elkay Water Solutions Corporation (ZWS)
Sector: Industrials
Exchange: NYSE
Founded: February 24, 1892
Listing Date: March 28, 2012
Fiscal Year End: December
Headquarters: United States, Milwaukee
CEO: Todd Alan Adams
Market Cap: $8.53B
Shares Outstanding: 165.86M
Current Stock Price:$51.42
Annual Dividend Yield:0.86%
Ex-dividend Date: May 20, 2026 (ET, historical basis)
As-of: August 12, 2026 (ET)
Q1-A2. How Does Zurn Elkay Make Money?
Zurn Elkay operates as a highly specialized, growth-oriented pure-play water management enterprise, generating revenue by designing, manufacturing, and marketing premium plumbing infrastructure, flow systems, and drinking water solutions. The company traces its historical roots to Erie, Pennsylvania, where John A. Zurn founded the original business in 1900, and Chicago, Illinois, where Elkay was established in 1920; the two entities merged in 2022 to form an undisputed market leader.
The company captures outsized economic value through a rigorous “specification-driven” business model. Rather than competing on price in the highly volatile retail residential market, Zurn Elkay’s engineers work directly with architects and commercial contractors to write proprietary part numbers into the blueprints of institutional, commercial, and municipal buildings. Because these components are mission-critical for plumbing integrity, hygiene, and building code compliance, substituting them late in the construction phase introduces immense redesign costs and liability. This creates a deeply entrenched, recurring revenue stream characterized by robust pricing power and high switching costs, allowing the company to command premium margins on products ranging from backflow preventers to the ubiquitous ezH2O bottle filling stations.
Q1-A3. Zurn Elkay’s Revenue Segments & Core Income Sources
Water Safety and Control: This segment acts as the highly profitable foundation of the enterprise, providing pressure-reducing valves, backflow preventers, and flow management systems that protect municipal water supplies from contamination and reduce overarching water consumption. This division benefits heavily from non-discretionary regulatory compliance and replacement demand, serving as a structural ballast during cyclical macroeconomic fluctuations.
Drinking Water (Filtration & Hydration): Born primarily from the Elkay merger, this segment is the company’s premier growth driver. It features the industry-standard ezH2O filtered bottle filling stations and the Liv EZ built-in home and commercial filtered dispensers. The strategic brilliance of this segment lies in its consumable tailwind: sales of proprietary filtration units have surged from under $25 million prior to the merger to an expected $60+ million in 2026, driven by intense public and regulatory anxiety surrounding PFAS (“forever chemicals”), lead, and microplastics.
Flow Systems & Hygienic/Environmental: This segment encompasses heavy-duty drainage systems, rough wall plumbing fixtures, and hygienic restroom accessories. While the Hygienic category remains the smallest in the portfolio, Flow Systems consistently outpaces the broader company average, embedding Zurn Elkay deeply into the institutional retrofit cycle and ensuring that the company captures value at every stage of commercial water usage.
Q1-A4. Who Are Zurn Elkay’s Competitors?
Direct Competitors: Zurn Elkay competes against a fragmented landscape of specialized industrial and building products manufacturers. Key rivals include A.O. Smith (AOS) in water heating, Watts Water Technologies (WTS) in valves and flow control, Advanced Drainage Systems (WMS) in municipal water management, and Fortune Brands Innovations (FBIN) and Masco (MAS) in plumbing fixtures.
Industry Position Assessment: Zurn Elkay commands an unrivaled, dominant position in the commercial filtered drinking water space, with Elkay standing as America’s No. 1 producer of bottle filling stations and sinks. Unlike diversified peers that suffer from the cyclical whiplash of retail residential housing, Zurn Elkay operates as a pure-play commercial water management entity. This hyper-focus on institutional retrofits and specification-driven sales grants the company superior pricing power, evidenced by its elite margin profile and ability to consistently pass inflation down to end consumers without sacrificing volume.
Q1-A5. Zurn Elkay Key Events: Past 12 Months
August 04, 2026Significant Insider Selling by Chief Administrative Officer
Description: Mark W. Peterson, CAO of Zurn Elkay, disposed of 25,000 shares in a transaction valued at approximately $1.33 million, executing the sales at a weighted average price of $53.02. This follows broader trends of heavy insider selling, including a massive $28 million liquidation by the CEO earlier in the trailing twelve months, signaling potential executive caution regarding the stock’s near-term valuation ceiling.
July 28, 2026Q2 2026 Earnings Release
Description: The company delivered a resounding earnings beat, reporting adjusted EPS of $0.50 (surpassing the $0.47 consensus) and net sales of $491 million, which represented a 10% organic core growth rate. Operating leverage was immense, driving adjusted EBITDA margins up 120 basis points to a record 27.7%, prompting management to aggressively raise their full-year sales, EBITDA, and free cash flow guidance.
July 20, 2026Strategic Acquisition of Intellihot
Description: Zurn Elkay executed a definitive agreement to acquire Intellihot, a privately held, disruptive manufacturer of commercial tankless condensing water heaters, for $109 million in cash ($100 million net of a tax asset). This acquisition represents a highly strategic adjacency move that immediately expands the company’s total addressable market by $1.1 billion, with management outlining a clear path for Intellihot to reach $100 million in sales at a 30% EBITDA margin within five to six years.
May 20, 2026Quarterly Cash Dividend Ex-Date
Description: The company recognized its regular quarterly cash dividend of $0.11 per share, payable on June 5, 2026. This dividend reflects the substantial 22% year-over-year dividend increase enacted at the start of the year, underscoring management’s commitment to returning excess cash to shareholders alongside aggressive share repurchases.
April 22, 2026Q1 2026 Earnings Release
Description: Zurn Elkay established a strong foundation for the year by delivering $433 million in net sales (11% core growth) and expanding adjusted EBITDA margins by 160 basis points to 26.8%. The company also utilized its pristine balance sheet to deploy $50 million toward repurchasing 1.0 million shares of common stock, further compressing the outstanding share count.
February 13, 2025Secondary Public Offering by Ice Mountain LLC and Share Repurchase
Description: Ice Mountain LLC, the holding entity representing the founding Katz family of Elkay, executed an underwritten secondary offering of 8.91 million shares at $35.00 per share. Concurrently, Zurn Elkay opportunistically repurchased 1.63 million of these shares directly from the underwriters for approximately $55 million, effectively retiring a portion of the overhang while generating zero new dilutive proceeds for the company.
February 04, 2025Q4 and Full Year 2024 Earnings Release
Description: The company concluded the previous fiscal calendar with record free cash flow generation of $317 million, demonstrating the flawless integration of the Elkay merger and the relentless margin-expanding power of the Zurn Elkay Business System (ZEBS). The results proved the company’s ability to drive 8% year-over-year core sales growth in a challenging macro environment.
Q1-A6. Step 1 Key Takeaways
Step 1 Summary: Zurn Elkay is an exceptionally profitable, pure-play commercial water management enterprise that has successfully weaponized its specification-driven business model to generate robust organic growth. The recent acquisition of Intellihot and the rapid adoption of its high-margin filtered hydration systems highlight a management team expertly compounding capital within highly defensible ESG-driven niches.
Top 3 Red Flags:
1 The heavy concentration of revenue tied to institutional and non-residential construction markets leaves the company vulnerable to prolonged high-interest-rate environments that could choke off commercial real estate financing and municipal budgets.
2 Substantial, unrelenting insider selling by top executives—most notably a $28 million liquidation by the CEO and recent sales by the CAO near the stock’s 52-week high—creates a psychological overhang and suggests management views the current premium valuation as fully priced.
3 The underlying margin dilution risk associated with the Intellihot acquisition; the subsidiary currently operates at low-teens EBITDA margins, and any failure to rapidly scale it to the 30% target could drag down Zurn Elkay’s elite consolidated margin profile.
Top 5 Key Financial/Operational Indicators for Next-Level Analysis:
1 Core organic sales growth trajectory (achieved 10% in Q2 2026, signaling strong resilience in the institutional pipeline).
2 Adjusted EBITDA margin expansion and operating leverage (hit a record 27.7% in Q2, with 40% incremental margins in the first half).
3 Free cash flow conversion and absolute generation (targeting at least $350 million for full-year 2026, enabling massive capital returns).
4 The penetration and attach rate of filtered drinking water units (management is targeting 70% of all units sold to be filtered by 2027, up from 50% in 2023).
5 Net debt leverage ratio dynamics (currently sitting at a historic public-company low of 0.3x, providing immense M&A optionality).
Top 3 Unconfirmed and Estimated:
1 The exact cadence and financial magnitude of the new product adjacencies scheduled for launch in late 2026 and 2027, which are expected to meaningfully expand the total addressable market.
2 The ultimate duration of the current institutional construction momentum, which is currently offsetting weakness in residential and softer pockets of general commercial building.
3 Whether the $60 million in uncollected IEEPA reciprocal tariffs will eventually be refunded in cash, providing another non-dilutive liquidity injection akin to the $48 million received in Q2.
Q2-A1. Does Zurn Elkay Have a Durable Economic Moat?
Entry barriers: Zurn Elkay boasts an incredibly wide and durable economic moat constructed upon formidable intangible assets and prohibitive switching costs. The company’s core strategy relies on a “specification-driven” model where mechanical engineers and architects write proprietary Zurn and Elkay components directly into the initial blueprints of commercial and institutional buildings. Because these highly engineered components—ranging from backflow preventers to NSF/ANSI certified ezH2O filtration systems—are required to meet stringent local building codes and health mandates, substituting them with cheaper alternatives during the construction phase introduces catastrophic liability and redesign costs for contractors. This dynamic effectively locks competitors out of the bidding process once a project is specified.
Pricing power: The company exercises near-monopolistic pricing power within its specialized niches. Plumbing infrastructure and water safety valves typically represent a fractional percentage of total commercial project costs, yet they are absolutely critical for securing occupancy permits. Consequently, building owners and contractors are highly price-inelastic. Zurn Elkay repeatedly leverages this dynamic to pass inflationary pressures directly to end consumers; in both the first and second quarters of 2026, strategic price increases contributed approximately 5% to overarching core growth without eroding volume demand.
Profitability defense: The robustness of the moat is best quantified by the company’s relentless profitability defense, orchestrated through the Zurn Elkay Business System (ZEBS). By applying strict 80/20 principles—focusing aggressively on the highest-margin, fastest-moving specified products while eliminating unprofitable SKUs—the company has structurally insulated its margins. Operating leverage has been spectacular, driving adjusted EBITDA margins from a baseline of 19.5% in early 2023 to a record-shattering 27.7% in Q2 2026. This proves the company can defend and expand its long-term return on invested capital regardless of broader economic stagnation.
Q2-A2. Is Zurn Elkay’s Growth Sustainable?
Industry structure and market growth outlook: Zurn Elkay operates within a steadily expanding total addressable market (TAM) that is structurally supported by aging infrastructure replacement cycles and powerful environmental, social, and governance (ESG) tailwinds. The recent $109 million acquisition of Intellihot radically expands this TAM by $1.1 billion, inserting the company into the fast-growing commercial tankless water heating sector—a space increasingly mandated by energy efficiency regulations and building owners seeking to eliminate the Legionella risks associated with stagnant tank water. Concurrently, intense public scrutiny over PFAS, microplastics, and lead contamination is driving a massive retrofit supercycle for the company’s NSF 42, 53, and 401 certified filtration systems in schools and hospitals.
Growth Sustainability: The fundamental nature of Zurn Elkay’s growth is deeply structural, tied to immutable health codes, energy efficiency legislation, and clean water mandates rather than transient consumer fads. Nevertheless, this growth narrative is subject to three essential downside scenarios:
1 A catastrophic, prolonged freeze in commercial real estate financing and municipal bond issuance that mechanically halts the non-residential construction and institutional retrofit pipeline.
2 A failure to efficiently integrate Intellihot into the broader Zurn Elkay ecosystem, resulting in a prolonged period where the subsidiary’s low-teens margin profile actively dilutes the parent company’s elite 27.7% EBITDA margin.
3 A severe regulatory rollback of municipal water safety standards and energy efficiency mandates, which would commoditize the premium filtered hydration and tankless water heating markets.
Q2-A3. How Does Zurn Elkay Allocate Capital & Return Cash?
Priorities and consistency: Management’s capital allocation strategy is a masterclass in disciplined shareholder value creation. Reinvestment is ruthlessly prioritized toward high-ROIC adjacencies and continuous improvement initiatives. The Intellihot acquisition perfectly exemplifies this, with management mapping a clear trajectory to achieve a double-digit return on invested capital within just three years. Simultaneously, the company returns immense volumes of cash directly to shareholders, executing $160 million in share repurchases in 2025 and an additional $100 million in the first half of 2026. This is augmented by a rapidly growing dividend, which was hiked by 22% year-over-year.
Capital Efficiency: The efficacy of this allocation is evident in the company’s pristine balance sheet. By generating massive free cash flow ($112 million in Q2 2026 alone), management has driven net debt leverage down to an unprecedented 0.3x, the lowest in its public company history. The firm’s normalized ROIC sits at a robust 14.39%, comfortably surpassing any standard weighted average cost of capital (WACC) and proving that every dollar retained for M&A or internal investment creates massive excess value.
Q2-A4. Step 2 Key Takeaways
Scoring Rationale:
Economic Moat (8/10): The specification-driven model and absolute pricing power create a formidable barrier to entry, though the business remains inherently tethered to physical construction cycles.
Growth Sustainability (7/8): Structural ESG tailwinds, strict health mandates, and brilliant TAM-expanding acquisitions secure a highly visible, multi-year growth runway.
Capital Allocation (6/7): Management executes flawlessly on Deleverage, aggressive share repurchases, and high-ROIC acquisitions, utilizing excess cash to aggressively shrink the equity base.
Step 2 Summary: Zurn Elkay commands a highly defensible economic moat forged by architectural specifications and regulatory health mandates. This monopoly-like positioning generates massive free cash flow, which management expertly allocates between aggressive share repurchases and strategic, TAM-expanding acquisitions.
💰 Step 3: Is Zurn Elkay Profitable? Financial Health Analysis
Q3-A1. Zurn Elkay’s Growth & Profitability Trends
Analysis of growth and revenue indicators: Zurn Elkay exhibits an elite trajectory of compounding fundamental growth. In the second quarter of 2026, the company delivered $491 million in net sales, achieving a 10% organic core growth rate that thoroughly validated the strength of institutional demand. Net income surged to $113 million (or $0.67 per diluted share), bolstered by strong operational execution and a unique $47.6 million refund from previously paid IEEPA reciprocal tariffs. Over a broader timeline, the company’s post-merger integration of Elkay has catalyzed average annual revenue growth of 16.8%, while earnings have exploded at a 37.7% annual clip, entirely eclipsing the broader building products industry’s single-digit growth averages.
Profitability margin and leverage verification: The ‘operating leverage’ effect is undeniably real and structurally entrenched. In Q2 2026, adjusted EBITDA reached $136 million, expanding the margin by 120 basis points to a record 27.7%. Most impressively, the company generated a 40% incremental EBITDA margin in the first half of the year, proving that every additional dollar of revenue flows disproportionately to the bottom line.
Q3-A2. How Profitable Is Zurn Elkay? (Margins & ROIC)
Capital Efficiency: Zurn Elkay’s normalized Return on Invested Capital (ROIC) stands at an exceptional 14.39%. Given that the standard industrial weighted average cost of capital (WACC) typically hovers between 7% and 9%, Zurn Elkay generates massive economic value added (EVA) on its invested base, proving the qualitative superiority of its asset-light assembly and specification model.
Return on Equity and Assets: Balance sheet efficiency is equally pristine, with the company commanding a Return on Equity (ROE) of 18.12% and a Return on Assets (ROA) of 10.79%.
Relative to its industrial peers, Zurn Elkay’s profitability profile is peerless, seamlessly leveraging its pure-play water management focus to achieve margins and returns that diversified, residentially exposed competitors simply cannot match.
Q3-A3. What Drives Zurn Elkay’s Returns? (ROIC Breakdown)
Industry-specific efficiency analysis: As a highly specialized industrial manufacturer, Zurn Elkay’s ROIC is mechanically driven by the ruthless optimization of its product mix and supply chain velocity via the Zurn Elkay Business System (ZEBS). By rigidly enforcing 80/20 principles—allocating capital strictly to the highest-volume, highest-margin proprietary components while pruning commoditized SKUs—management has engineered an 820 basis point expansion in adjusted EBITDA margins over the last 14 quarters (rising from 19.5% in early 2023 to 27.7% in Q2 2026).
Furthermore, the strategic shift toward high-margin filtration consumables acts as a massive margin accelerant. The company anticipates that 60% of all drinking water units sold in 2026 will be filtered—up from 50% in 2023—with a firm target to reach 70% by 2027, structurally elevating the baseline profitability of the entire enterprise.
Q3-A4. Are Zurn Elkay’s Earnings High Quality?
Cash flow vs. Net Income: The quality of Zurn Elkay’s earnings is impeccable, entirely devoid of aggressive accounting accruals. In Q2 2026, the company converted its $136 million of adjusted EBITDA into $112 million of pure free cash flow. This exceptional cash conversion rate proves that the company’s book profits are backed dollar-for-dollar by liquid cash inflows.
This dynamic is a long-standing hallmark of the business; the company generated a record $317 million in free cash flow in FY2025, perfectly mirroring its net income trajectory and confirming that fictitious gains do not pollute the income statement.
Q3-A5. Is Zurn Elkay’s Balance Sheet Healthy? (Debt & Leverage)
Comprehensive Financial Stability: Zurn Elkay operates from a position of absolute financial invulnerability. As of Q2 2026, the company held $365.0 million in cash and cash equivalents against a total debt load of just $499.1 million. Liquidity metrics are sterling, featuring a quick ratio of 2.04 and a current ratio of 3.05, ensuring immediate coverage of all short-term liabilities.
Leverage and Refinancing: Net debt leverage has been aggressively crushed down to 0.3x, the absolute lowest level in the company’s history as a public entity. With $540.3 million of unused capacity on its revolving credit facility, Zurn Elkay faces zero refinancing risk and holds near-infinite optionality to execute further cash acquisitions (like the $109 million Intellihot deal) without stressing solvency.
Interest Repayment: The company’s interest coverage ratio is a dominant 14.87x, guaranteeing that the operating cash generated by its core business is vastly sufficient to service its minimal financial expenses.
Q3-A6. Step 3 Key Takeaways
Scoring Rationale:
Profitability·Capital Efficiency (9/10): A staggering 40% incremental margin and an elite 14.39% ROIC underscore the immense power of the ZEBS operating framework and specification-driven moat.
Cash Flow·Profit Quality (7/8): Near-perfect cash conversion guarantees that every dollar of reported earnings translates directly into deployable free cash flow.
Financial Soundness·Debt Management (7/7): A fortress balance sheet marked by 0.3x net leverage and vast liquidity provides the ultimate defense against macroeconomic shocks.
Step 3 Summary: Zurn Elkay is a masterclass in industrial profitability, utilizing a pristine balance sheet and elite cash conversion mechanics to perpetually fund aggressive shareholder returns and strategic growth without incurring an ounce of financial strain.
Evidence: Zurn Elkay adheres to highly standardized point-of-sale and distributor sell-through revenue recognition models typical of premier industrial manufacturers, with zero history of SEC inquiries, whistleblower complaints, or forced restatements.
Cost capitalization: not found
Evidence: The company expenses research, development, and standard operating costs cleanly. When a massive $47.6 million one-time cash refund from previously paid IEEPA reciprocal tariffs arrived in Q2 2026, management transparently recorded it as a reduction to cost of sales but strictly excluded it from adjusted EBITDA and free cash flow to prevent fundamental distortion.
Sharp increase in accounts receivable and inventory: not found
Evidence: Working capital is ruthlessly optimized under the 80/20 ZEBS framework. The record free cash flow generation ($112 million in Q2 2026) fundamentally contradicts any thesis of inventory stuffing or aggressive channel loading.
Evidence: The aforementioned $48 million cash refund for IEEPA reciprocal tariffs artificially spiked GAAP earnings in Q2 2026. However, management’s proactive exclusion of this windfall from their adjusted metrics demonstrates high accounting integrity, ensuring the market models the core business accurately.
Q4-A2. Is Zurn Elkay Overspending? (Capex & Capital Cycle)
➖ Not applicable: Zurn Elkay operates a highly agile, asset-light assembly and procurement model rather than a capital-intensive, heavy-manufacturing paradigm. The traditional capital-cycle lens of massive oversupply risk does not apply, as capacity expansions are modular and strictly aligned with highly visible, specification-driven institutional demand.
Q4-A3. How Sound Is Zurn Elkay’s Cash Flow?
Cash flow stability: The stability and sheer volume of Zurn Elkay’s cash flow are unassailable. The firm generated a colossal $317 million in free cash flow across FY2025 and continued the trend with $112 million in Q2 2026 alone. The core business effortlessly funds massive share repurchases ($100 million in H1 2026), cash dividends, and nine-figure acquisitions (the $109 million Intellihot buyout) internally, completely negating any reliance on external debt or equity financing.
Warning signals: There are absolutely no negative operating cash flow warnings present in the financials. Operating cash flow consistently matches or exceeds book net income, firmly verifying the absence of fictitious gains.
Q4-A4. Is Zurn Elkay Diluting Shareholders?
⏪ Confirmed (Past) Dilution: The company is aggressively shrinking its share base, effectively reversing dilution. Management deployed $160 million for stock repurchases in 2025 and an additional $100 million in the first half of 2026, neutralizing any stock-based compensation and generating immense EPS accretion.
⏩ Potential (Future) Dilution & Overhang: The most significant overhang risk originates from Ice Mountain LLC (the Katz family holding entity). However, this was substantially de-risked in Q1 2025 when they liquidated 8.9 million shares in a secondary offering—1.63 million of which Zurn Elkay immediately bought back. The remaining Katz shares are locked up until October 31, 2026, providing a clear runway free of insider dumping. Given the company’s 0.3x leverage, future capital raises via equity dilution are virtually impossible.
Definition: Non-GAAP and FCF definitions unified (IEEPA tariff refund strictly excluded from adjusted metrics) ➡ (Pass)
Number of shares: basic vs. diluted unified (165.86M outstanding used universally across metrics) ➡ (Pass)
Unit: USD unified ➡ (Pass)
Single Value Confirmation: Single value mathematically confirmed across platform and official SEC disclosure data ➡ (Pass)
Q4-A6. Step 4 Key Takeaways
Scoring Rationale:
Accounting anomalies·distortion signals (7/8): Management exercises supreme transparency, perfectly isolating a massive one-time tariff refund to preserve accurate fundamental modeling.
Cash flow warning signals (7/7): Pristine cash flow conversion with zero reliance on external financing to fund aggressive M&A and capital returns.
Dilution factors (5/5): Management is weaponizing its free cash flow to rapidly shrink the share base, aggressively combating and reversing dilution.
Q5-A1. Can You Trust Zurn Elkay’s Management? (Guidance Track Record)
Guidance Hit Rate: CEO Todd Adams and his executive team operate with a disciplined “under-promise and over-deliver” philosophy. In Q2 2026, they decisively surpassed Wall Street consensus, beating the $0.47 EPS estimate by $0.03 and surpassing revenue projections by nearly $8 million. Validating this momentum, management subsequently raised their full-year adjusted EBITDA guidance to a formidable $503-$513 million.
Transparency: Executive communication is refreshingly clear. The team proactively isolates organic core sales from one-time events and provides highly specific, accountable long-term targets—such as achieving a 70% filtered ezH2O adoption rate by 2027 and demanding a 30% margin for the newly acquired Intellihot unit within 5-6 years.
Q5-A2. What Are Zurn Elkay Insiders Doing?
Insider Trading Status: Insider sentiment currently flashes a glaring warning signal. On August 4, 2026, CAO Mark W. Peterson disposed of 25,000 shares for $1.33 million at an average price of $53.02. Far more concerning is the activity of CEO & Chairman Todd Adams, who liquidated a staggering $28 million worth of shares over the trailing twelve months at an average execution price of roughly $52.68. Crucially, there have been zero open-market cluster buys recorded over the past year to offset this intense selling pressure.
Executive Confidence Signals: While executives routinely sell for tax and diversification reasons, the sheer magnitude of the CEO’s liquidation near the stock’s absolute 52-week high ($55.00) injects a heavy psychological overhang into the market. It strongly implies that the executives with the deepest visibility into the company’s forward pipeline view the current premium valuation as fully priced.
Q5-A3. Is Zurn Elkay’s Management Aligned With Shareholders?
Voting Rights and Governance: Zurn Elkay is governed by a standard, equitable single-class voting structure, fully protecting the rights of minority shareholders without the distortions of dual-class shares. The Katz family (via Ice Mountain LLC) maintains a massive, though non-controlling, vested interest post-merger, ensuring legacy accountability.
Performance Indicators and Alignment: The executive compensation framework is deeply intertwined with adjusted EBITDA margin expansion and free cash flow generation—the exact metrics required to fund the company’s aggressive deleveraging and share repurchase programs. Despite the recent wave of block sales, management still retains approximately 2.3% of the outstanding equity (valued at nearly $193 million), ensuring structural alignment with long-term value creation.
Q5-A4. Step 5 Key Takeaways
Scoring Rationale:
Management Trust (5/5): Flawless execution on quarterly guidance beats and highly transparent, conservative forecasting forge immense institutional trust.
Insider Trends (2/5): The massive $28 million liquidation by the CEO and continued selling by the CAO near all-time highs act as a severe psychological headwind, indicating a distinct lack of buying conviction.
Governance·Compensation System (4/5): An equitable single-class structure tied to rigorous margin and cash-generation KPIs properly aligns executive incentives with shareholder returns.
Step 5 Summary: While management executes flawlessly on operational guidance and capital allocation frameworks, the aggressive insider dumping by top executives near current price peaks limits the overall alignment score, introducing significant valuation anxiety.
⛵ Step 6: Zurn Elkay Market Flow & Sentiment
Q6-A1. Analyst Consensus vs Zurn Elkay Guidance
Guidance gap: Market expectations are completely synchronized with management’s bullish trajectory. Following the decisive Q2 2026 beat, management raised full-year EBITDA guidance to $503-$513 million, comfortably stepping over previous Street consensus targets. This bold upward revision triggered an immediate cascade of positive adjustments, with 10 separate analysts revising their EPS estimates upward for the upcoming period.
Sentiment shifts: Sell-side sentiment borders on euphoric. The average analyst price target has ratcheted up to $58.00 (implying a +12.8% upside), fueled by deep conviction in the resilience of institutional building markets and the TAM-expanding potential of the Intellihot acquisition. Major firms like Stifel and Barclays have initiated or reiterated firm ‘Buy’ ratings with $59 targets, signaling widespread institutional endorsement.
Q6-A2. What Is Zurn Elkay’s Short Interest?
Institutional Trends: Institutional ownership is incredibly dominant, commanding effectively ≈102% of the float (a mathematical quirk driven by shorting and reporting delays). Heavyweight passive and active managers like BlackRock (14.16%) and Vanguard (10.03%) hold massive, sticky positions, establishing a concrete floor beneath the stock price.
Short Selling Indicators: Short interest is virtually non-existent, sitting at a negligible 3.41% with a Days-to-Cover ratio of merely 1.6 days. This metric confirms the complete absence of aggressive, convicted short-selling pressure. A short squeeze is mathematically impossible here; the broader market unequivocally views ZWS as a highly stable, elite compounder rather than a fundamentally flawed battleground stock.
Q6-A3. Step 6 Key Takeaways
Scoring Rationale:
Consensus vs Guidance (3/3): The emphatic beat-and-raise quarter catalyzed universal upward earnings revisions across the sell-side ecosystem.
Supply·Short Interest (1/2): Extremely robust institutional backing provides a rigid price floor, though the negligible short interest removes any technical momentum-based squeeze catalysts.
Step 6 Summary: Zurn Elkay enjoys impenetrable institutional support and sharply upward-trending analyst estimates, shielded entirely by low short interest in a highly frictionless market environment.
🚀 Step 7: Zurn Elkay Catalysts & Price Triggers
Q7-A1. What Could Move Zurn Elkay Stock? (Top 3 Catalysts)
1 The Intellihot Integration and Commercial Synergy Ramp
Timing: Next 6-12 months
Success Conditions: Zurn Elkay successfully routes Intellihot’s commercial tankless water heaters through its undisputed institutional distribution channels, rapidly accelerating the subsidiary toward its aggressive $100 million sales / 30% margin target.
Failure Risk: The integration distracts core management, and the subsidiary’s current low-teens EBITDA margin stubbornly dilutes Zurn Elkay’s elite 27.7% consolidated margin for longer than the market expects.
2 Regulatory Expansion of PFAS and Lead Filtration Mandates
Timing: Next 6-12 months
Success Conditions: Escalating municipal and federal mandates regarding PFAS (“forever chemicals”) and lead contamination force public schools, hospitals, and commercial buildings to mandate Elkay’s NSF 42/53/401 certified ezH2O filtered stations, rapidly pushing the filtered unit mix past management’s 70% target and locking in a massive recurring revenue stream of replacement filters.
Failure Risk: Environmental regulation rollbacks or extended compliance deadlines slow the urgency of institutional retrofit demand, commoditizing the premium hydration market.
3 Unlocking the “Adjacency M&A” Pipeline
Timing: Mid-to-late 2027
Success Conditions: Utilizing its massive $540 million revolver capacity and historic 0.3x leverage, management announces a highly accretive, surprise acquisition in a high-margin water quality or automation adjacency, proving the thesis that ZWS is a relentless serial compounder.
Failure Risk: Management overpays for a declining asset in an attempt to buy growth, wrecking the pristine balance sheet.
Q7-A2. Zurn Elkay’s Earnings Revision Trend
Tracking EPS estimate changes: Over the past 90 days, consensus estimates for FY2026 EPS have surged aggressively. Driven by the robust Q1 and Q2 earnings surprises and the upwardly revised EBITDA guidance, the consensus estimate ratcheted up from $1.47 to $1.73, and currently sits at a confident forward projection of $1.83.
Momentum assessment: The frequency and intensity of these upward revisions—spanning 10 independent analysts—firmly establishes intense earnings momentum. The market is actively chasing Zurn Elkay’s expanding profitability, confirming that expectations for fundamental outperformance are deeply embedded in the stock’s near-term trajectory.
Q7-A3. Step 7 Key Takeaways
Scoring Rationale:
Catalyst (6/7): The $1.1 billion TAM expansion via Intellihot and the secular ESG filtration mandates provide incredibly durable, highly visible, and heavily regulated growth runways.
EPS Trend (3/3): A flawless, aggressive upward trajectory in EPS estimates led directly by management’s own confident guidance hikes.
Step 7 Summary: Backed by aggressive upward earnings revisions and clear, specification-driven catalysts in water safety and advanced heating, Zurn Elkay possesses exceptional forward fundamental momentum.
⚖️ Step 8: Is Zurn Elkay Fairly Valued? Valuation Analysis
Scoring Rationale: Across almost every absolute multiple metric, Zurn Elkay screens as highly expensive. The market is pricing in significant structural growth and elite margin execution, leaving virtually zero margin of safety at an absolute level.
📌 (1) Axis Q8-A1 Score:-2
Q8-A2. Zurn Elkay vs Peers: Valuation Comparison
Multiple selection based on peer comparison: Forward PER
Calculation of peer-to-peer deviation rate: +28.8%
Scoring Rationale: Compared to a specialized peer group average of 24.3x (which includes WTS, AOS, and SSD), Zurn Elkay trades at a massive premium approaching 30%, categorizing it firmly in the overvalued tier relative to its direct industry benchmarks.
📌 (2) Axis Q8-A2 Score:-2
Q8-A3. Is Zurn Elkay Cheap or Expensive vs Its History?
Comparison Indicators: Trailing PER
Scoring Rationale: As Zurn Elkay’s stock price recently grazed its 52-week high of $55.00, its multiples remain compressed near the top 20-40% of its historical 5-year post-spin valuation band, indicating elevated historical expensiveness.
📌 (3) Axis Q8-A3 Score:-2
Q8-A4. What Growth Is Priced Into Zurn Elkay? (Reverse DCF)
Implied Growth Rate:13.5%
1 Methodology: PEG-based inversion
2 Core assumptions: Requires a PEG of roughly 2.0 applied against a 27.86x Forward P/E to rationally justify the current stock price.
Achievable Growth Rate:10.5%
Basis: The recent 10% organic core sales growth rate combined with management’s stated margin expansion trajectory.
Scoring Rationale: The market implicitly demands sustained double-digit compounding (meaning growth difficulty is somewhat high) that meaningfully exceeds the company’s baseline 10% organic strength. This leaves the stock somewhat expensive and vulnerable to any slight miss in execution.
📌 (4) Axis Q8-A4 Score:-2
Q8-A4-1. What Growth Hurdle Does the Market Demand From Zurn Elkay? (Reverse DCF Alternative)
(3) Axis Q8-A3 (Historical Band Position): Overvalued
(4) Axis Q8-A4 (Justification for Growth): Overvalued
The mechanical valuation framework is unanimous: all four primary valuation axes definitively conclude that the stock is Overvalued, resulting in a perfect directional match and avoiding any cross-verification penalty.
Scoring Rationale: While Zurn Elkay’s pristine balance sheet (0.3x leverage) and elite 40% incremental margins intuitively justify a structural quality premium, the systematic valuation framework demands strict adherence to the metrics; thus, no arbitrary upward adjustments are applied.
Commentary: The systematic valuation framework severely penalizes Zurn Elkay for its premium pricing across absolute, relative, and historical parameters. The market has fully priced in the flawless execution of the ZEBS margin-expansion playbook.
Step 8 Summary: Zurn Elkay is a phenomenal, elite-tier business trading at a remarkably steep premium, forcing investors to pay up significantly for its quality and leaving very little margin of safety at current trading levels.
💀 Step 9: What Are the Risks of Zurn Elkay? Fatal Risks & Pre-Mortem
Q9-A1. What Are the Biggest Risks to Zurn Elkay?
1 Macroeconomic contraction in non-residential construction:
Cause: A prolonged high-interest-rate environment severely stifles institutional, municipal, and commercial building budgets, choking off the financing required for major retrofits.
Impact: Financial (Sales stall as retrofit and new-build projects are delayed indefinitely).
Mitigation/Monitoring Indicators: Track the Architecture Billings Index (ABI) and Dodge Construction Network starts for early signs of pipeline contraction.
2 Margin dilution from the Intellihot integration:
Cause: Zurn Elkay fails to rapidly scale Intellihot’s low-teens margin profile toward its stated 30% target, bogging down operational focus.
Impact: Financial (Consolidated adjusted EBITDA margins plateau or contract from the current 27.7% record).
Mitigation/Monitoring Indicators: Monitor quarterly management commentary on Intellihot’s specific margin accretion and synergy realization.
3 Supply chain and raw material inflation:
Cause: Resurgent, sticky inflation in copper, steel, and advanced plastics outpaces the company’s ability to push through its standard 3-4% annual price increases.
Impact: Financial (Gross margins compress as raw input costs spike unexpectedly).
Mitigation/Monitoring Indicators: Track producer price indices for industrial metals and the company’s reported price-to-cost realization.
Q9-A2. How Sensitive Is Zurn Elkay to the Economy?
1 Interest Rates and Institutional Budgets (⬇): A “higher-for-longer” rate environment directly suppresses the financing available for large-scale commercial and municipal infrastructure retrofits, compressing the core sales volumes that power Zurn Elkay’s flow systems division.
2 Regulatory Environmental Mandates (⬆): Aggressive federal and state implementations of PFAS and lead filtration requirements structurally detach Zurn Elkay’s ezH2O sales from the broader economic cycle, providing highly resilient value and sales growth regardless of GDP fluctuations.
Q9-A3. Zurn Elkay Pre-Mortem: What Could Go Wrong?
1 The Commercial Real Estate Collapse: A systemic breakdown in commercial real estate financing halts all office, retail, and hospitality upgrades, wiping out a massive swath of Zurn Elkay’s end-market demand.
Early Warning Signal: Major regional banks freeze commercial real estate lending, triggering widespread project cancellations in the Dodge Momentum Index.
2 The “Forever Chemical” Regulatory Rollback: A severe deregulatory political shift removes municipal mandates for advanced water filtration, suddenly commoditizing the premium drinking water market.
Early Warning Signal: The EPA officially walks back enforcement of the latest stringent PFAS/lead limits for municipal water systems.
3 Intellihot Becomes a Margin Anchor: The $109 million acquisition proves to be an overvalued misstep, as established HVAC giants fiercely defend their turf, trapping Intellihot in an unwinnable price war.
Early Warning Signal: Zurn Elkay quietly stops reporting Intellihot’s standalone margin trajectory during earnings calls, obscuring its dilution.
Q9-A4. Risk Adjustment Score
Reason for Scoring: The risks are entirely qualitative concerns at this stage. Management exerts massive control over margins via ZEBS, and current institutional demand remains demonstrably strong. However, heavy insider selling and exposure to cyclical construction warrant a minor baseline psychological penalty.
📊 Risk Adjustment Score:-3 pts
Step 9 Summary: Zurn Elkay’s risks are highly manageable, primarily tied to overarching macro construction cycles and minor M&A integration hurdles, presenting zero immediate structural threats to the core business model.
🎯 Step 10: Zurn Elkay Final Verdict: Score & Rating
Commentary: The company’s phenomenal fundamental operating performance, defined by 40% incremental margins and fortress-level cash flows, establishes an incredibly high foundational score. However, the heavy valuation penalty associated with its premium multiples slightly suppresses the final output, categorizing the stock as a high-quality, long-term holding rather than a screaming absolute-value bargain.
Q10-A2. Should You Buy Zurn Elkay? (Recommendation)
Recommendation:Hold
Commentary: Investors should confidently hold this elite industrial compounder, allowing the Zurn Elkay Business System (ZEBS) to continue generating robust free cash flow and dividend growth. However, new capital deployment should be paused until a more advantageous valuation entry point materializes or a broader market pullback occurs.
Q10-A3. Investment Thesis in One Line
Zurn Elkay is a phenomenally profitable, cash-gushing pure-play water manager riding massive secular ESG tailwinds, but its steep valuation premium demands flawless execution and warrants patience for a better entry point.
Q10-A4. Zurn Elkay’s Price Trend & Key Drivers
Stock Price Trends Over the Past 12 Months:Sideways movement ➡️
July 28, 2026Q2 2026 Earnings Surprise and Raised Guidance
Description: The company delivered a powerful double-beat, featuring 10% organic growth and a record 27.7% EBITDA margin, proving the resilience of institutional demand. ➡ Stock Price Surge
July 20, 2026Acquisition of Intellihot Announced
Description: Zurn Elkay signaled its aggressive entry into the $1.1B commercial tankless water heater market, showcasing management’s willingness to deploy its massive cash pile for TAM expansion. ➡ Stock Price Appreciation
August 04, 2026High-Volume Insider Selling
Description: A large block sale by the CAO (following massive $28M sales by the CEO earlier in the year) injected fierce psychological resistance near the stock’s 52-week highs. ➡ Sideways Consolidation
Q10-A5. Action Plan
Current Price:$51.42
Buy Zone:$48.00 ($46.00–$50.00)
(1) Calculation of Fundamental Value: From the perspective of securing the ‘Margin of Safety,’ entering below the psychological $50 barrier provides a critical buffer against cyclical construction downturns and aligns the P/E closer to historical peer norms.
(2) Momentum Premium/Discount Application: Given the elite 40% incremental margins and the pristine 0.3x balance sheet, Zurn Elkay deserves a structural premium; however, aggressive buying should be restricted to dips below key technical support levels to avoid paying peak multiples.
(3) Conclusion: The $48.00 midpoint represents a highly balanced entry that respects the company’s premium operational quality while protecting against the current multiple overextension.
Price Target:$58.01
Expected Return:+12.8% (vs. current price)
📍 Select target stock price calculation criteria:
Forward P/E Multiple — As a highly profitable industrial compounder, the market strictly values Zurn Elkay on its forward earnings and cash-generation capability.
🧮 Price Target Calculation Formula:
Per share indicator based (Forward PER, P/FCF, etc.): $1.83 × 31.70 = $58.01
Basis for applying the multiple: Historical valuation band — 31.70x — A premium multiple is retained to account for the company’s unrivaled ROIC (14.39%) and structurally expanding margins.
Conditions and timing for reaching price target: Accelerated market share gains from the Intellihot tankless water heater integration, paired with Q3/Q4 earnings beats that push FY2026 EBITDA to the absolute top end of the $513 million guidance.
Stop Loss:$42.00 ($41.00–$43.00)
Action trigger upon catalyst achievement:
1 Intellihot reaches a 20%+ EBITDA margin run-rate earlier than the 5-year target
Description: Proves management can rapidly scale acquisitions without margin dilution, justifying further high-ROIC M&A. 👉 Increased Holdings (Buy)
2 Filtered drinking water units exceed 65% of the portfolio mix
Description: Confirms the structural shift toward ESG-mandated filtration is accelerating, locking in high-margin recurring replacement revenues. 👉 Hold/Accumulate
3 Unveiling a surprise share repurchase authorization expansion
Description: Signals management believes the stock is undervalued even at premium multiples, putting a hard fundamental floor under the stock price. 👉 Increased Holdings (Buy)
Action trigger upon risk realization:
1 Management lowers full-year FCF guidance due to working capital blowouts
Description: Breaks the core thesis of Zurn Elkay as a flawless cash-converter, demanding an immediate re-rating of the stock’s premium multiple. 👉 Reduction in Holdings (Sell)
2 Non-residential construction metrics (like the ABI) collapse into deep recession territory
Description: Signals that the institutional pipeline will dry up, mechanically compressing Zurn Elkay’s volume growth in the medium term. 👉 Hold (Stop-Loss monitoring)
Description: Suggests executives foresee structural headwinds invisible to the public markets, eroding management trust. 👉 Reduction in Holdings (Sell)
Customized Strategy Guide by Investment Preference:
Defensive Investors: Maintain current holdings and collect the secure dividend, but restrict new capital deployment unless the stock pulls back into the mid-$40s to secure a wider margin of safety against institutional construction cyclicality.
Neutral Investors: Hold existing shares and selectively write covered calls at the $55 strike to generate yield while the stock digests its recent run-up and premium valuation.
Aggressive Investors: Accumulate shares on minor dips into the $48 Buy Zone, betting that the Intellihot integration and relentless 40% incremental margins will force analyst upgrades and blow past current conservative price targets.
🕵️♂️ Deep Dive Analysis
Q1: Is Zurn Elkay’s Dependence on Non-Residential Construction Its Biggest Weakness?
Analysis: Zurn Elkay derives the vast majority of its revenues from institutional, commercial, and municipal building markets, making it inherently sensitive to the macroeconomic cycles governing these sectors. While the company deftly avoids the extreme, rate-sensitive volatility of the retail residential housing market, non-residential construction is still inextricably linked to interest rates, commercial real estate financing health, and municipal bond issuance. If a “higher-for-longer” rate environment chokes off institutional lending or if post-pandemic office retrofits dry up entirely, the company’s core sales volume would face severe mechanical headwinds. However, this weakness is heavily mitigated by the non-discretionary nature of its products. Water safety regulations requiring backflow preventers and Legionella controls, combined with powerful ESG mandates enforcing PFAS filtration, force building owners to upgrade infrastructure regardless of the broader macro environment. Furthermore, Zurn Elkay is deeply entrenched in the less volatile, publicly funded education and healthcare verticals, thoroughly shielding it from pure commercial office exposure. The specification-driven model guarantees that when a building is built or retrofitted, Zurn Elkay products are essentially guaranteed to be used.
Judgment:Neutral — While macroeconomic cyclicality is a genuine threat to volume growth, the non-discretionary, regulatory-driven nature of water safety upgrades provides a massive, structural floor beneath demand, severely dampening the impact of construction slowdowns.
Q2: Can Zurn Elkay’s 27x Forward P/E Be Justified by the Intellihot Acquisition and Margin Expansion?
Analysis: A forward P/E approaching 28x is exceptionally rich for an industrial building products company, even one with a pristine balance sheet. The market is essentially pricing in flawless, perpetual execution of the Zurn Elkay Business System (ZEBS). To mathematically justify this valuation, Zurn Elkay must sustain its elite 40% incremental EBITDA margins and successfully scale the recent $109 million Intellihot acquisition without missing a beat. Intellihot opens a massive $1.1 billion total addressable market in commercial tankless water heaters. If Zurn Elkay can leverage its unrivaled institutional distribution channels to drive Intellihot’s sales to the $100 million target while simultaneously expanding its low-teens margin to 30%, the resulting cash flow surge would rapidly compress the forward valuation multiple. However, the current price leaves absolutely no room for integration missteps, margin compression, or macroeconomic deceleration. The market has already awarded the company credit for synergies that will take three to five years to fully realize.
Judgment:Overvalued — The market has preemptively credited Zurn Elkay with future integration successes and sustained margin expansions, requiring operational perfection just to maintain the current stock price, stripping away the margin of safety.
Q3: How Significant is the $1.1 Billion Addressable Market Expansion from the Intellihot Tankless Water Heater Deal?
Analysis: The acquisition of Intellihot is a masterstroke in capital allocation and TAM expansion. For $109 million in cash ($100 million net of tax assets), Zurn Elkay acquired a highly disruptive player in the high-efficiency commercial tankless water heating space. This adjacency perfectly matches Zurn Elkay’s core competency: producing specifiable, highly engineered water solutions serving healthcare, education, and hospitality. Commercial tankless heaters are gaining rapid market share due to sweeping energy efficiency mandates, significantly smaller mechanical-room footprints, and the eradication of standing water—which critically mitigates Legionella bacteria risks. By plugging Intellihot into its dominant wholesale and contractor channels, Zurn Elkay aims to triple Intellihot’s current $37 million sales base to $100 million within 5-6 years, transforming a niche player into a high-margin powerhouse and proving the immense scalability of the ZEBS framework. The deal is expected to deliver a double-digit ROIC in just three years.
Judgment:Positive — It is a highly strategic, TAM-expanding acquisition that perfectly leverages the company’s existing distribution moat to attack a rapidly growing, ESG-aligned product category with massive cross-selling potential.
Q4: Will PFAS and Lead Filtration Regulations Drive Outsized Growth for the Elkay ezH2O Product Line?
Analysis: The 2022 Elkay merger permanently secured Zurn Elkay’s dominance in commercial drinking water. While the ezH2O bottle filling stations are already ubiquitous, the true, compounding growth engine lies in the filtration upgrades. Growing public awareness and tightening EPA regulations regarding PFAS (“forever chemicals”), lead, and microplastics are forcing schools and municipalities to retrofit existing, unfiltered infrastructure. Elkay’s proprietary filters are NSF/ANSI 42, 53, and 401 certified specifically to eradicate these contaminants. Management noted a massive structural shift: filtered units are expected to account for 60% of drinking water sales in 2026, with a firm target of 70% by 2027 (up from just 50% in 2023). This shift not only drives higher upfront Average Selling Prices (ASPs) but creates a highly lucrative, recurring revenue stream from ongoing, required filter replacements that building owners must execute to maintain compliance.
Judgment:Positive — Strict environmental regulations guarantee a durable, multi-year upgrade supercycle for commercial hydration, permanently locking in high-margin recurring revenues that scale linearly with the installed base.
Q5: What Impact Does the $48 Million IEEPA Tariff Refund Have on Zurn Elkay’s Long-Term Capital Allocation?
Analysis: In the second quarter of 2026, Zurn Elkay recognized a massive $47.6 million cash refund related to previously paid IEEPA reciprocal tariffs. While management prudently and transparently excluded this windfall from adjusted EBITDA and free cash flow metrics to maintain operational clarity, the cash injection is entirely real and highly impactful. This non-dilutive influx directly bolstered the balance sheet, helping drive net debt leverage down to a pristine 0.3x. The sudden liquidity essentially fully funded the $50 million in share repurchases executed during the quarter, allowing the company to aggressively shrink its equity base without touching a dime of its core operating cash. With another $60 million in uncollected tariffs still off the balance sheet, future refunds could serve as stealth funding mechanisms for further aggressive buybacks or bolt-on acquisitions.
Judgment:Positive — It provides a massive, non-dilutive liquidity injection that accelerates deleveraging and fuels aggressive share repurchases without compromising the operating cash flow required for organic growth.
Q6: Can the Zurn Elkay Business System (ZEBS) Sustain Incremental EBITDA Margins Above 40%?
Analysis: Zurn Elkay’s profitability metrics are stunning, driven entirely by the ruthless application of the Zurn Elkay Business System (ZEBS). By leaning heavily on 80/20 principles—simplifying product lines, cutting low-margin SKUs, and optimizing supply chains—management has driven adjusted EBITDA margins from 19.5% in early 2023 to a record 27.7% in Q2 2026. In the first half of 2026, the company achieved a staggering 40% incremental EBITDA margin, blowing past its historical 35% framework. However, sustaining 40% incrementals indefinitely is mathematically improbable. As the easiest, low-hanging cost-cutting synergies from the Elkay merger are fully realized, future margin expansion must rely heavily on favorable product mix shifts (e.g., higher filtered ezH2O adoption) rather than raw cost extraction. The integration of the lower-margin Intellihot business will also serve as a near-term margin headwind.
Judgment:Neutral — While ZEBS is a proven, elite operating system that will protect downside margins, expecting incremental margins to stay permanently above 40% is overly optimistic; baseline margins will likely plateau near 30% as integration synergies mature.
Q7: Are High Insider Sales by CEO Todd Adams and CAO Mark Peterson a Warning Sign for Shareholders?
Analysis: Insider transaction data reveals significant, continuous executive selling. CEO Todd Adams liquidated approximately $28 million in stock over the past year at prices near $52.68, while CAO Mark Peterson sold $1.33 million at $53.02 in August 2026. While executives routinely sell for tax, options execution, or diversification purposes, the sheer volume of these sales near the stock’s 52-week high ($55.00) is difficult to ignore. It suggests that management, who possesses the deepest, most accurate visibility into the company’s forward pipeline and the upcoming Intellihot integration hurdles, may believe the stock is fully valued at nearly 28x forward earnings. The absolute lack of any offsetting open-market purchases by insiders further cements a lack of conviction in near-term multiple expansion.
Judgment:Negative — Aggressive cashing out by top executives at premium multiples creates a severe psychological ceiling on the stock and signals to the market that the easy, outsized gains have already been made.
Q8: Does Zurn Elkay Possess Sufficient Pricing Power to Offset Lingering Inflation in Raw Plumbing Materials?
Analysis: The plumbing and water infrastructure sector is heavily exposed to raw material inflation, particularly in copper, brass, stainless steel, and advanced plastics. However, Zurn Elkay has demonstrated ironclad pricing power that completely insulates its gross margins. In both Q1 and Q2 of 2026, strategic price increases contributed approximately 5% to the company’s core growth. Because Zurn Elkay’s products are highly specified by engineers and represent a critical but small fraction of total commercial building costs, contractors are forced to absorb these price hikes. Risking regulatory compliance failures by switching to cheaper, un-specified alternatives is simply not a viable option in commercial construction. This dynamic allows Zurn Elkay to effortlessly protect its margins and pass inflation directly to the end customer.
Judgment:Positive — The specification-driven moat completely insulates the company from raw material inflation, granting it near-absolute pricing power in its niche and guaranteeing margin stability.
Q9: How Will Smart, Connected Plumbing Ecosystems (plumbSMART) Change Zurn Elkay’s Recurring Revenue Mix?
Analysis: Zurn Elkay is aggressively modernizing commercial plumbing through its plumbSMART connected ecosystem. By integrating IoT sensors into backflow preventers, safety valves, and ezH2O bottle fillers, the company allows facility managers to remotely monitor water usage, track filter life, and predict maintenance needs (e.g., detecting relief valve discharge before a catastrophic failure). This shifts the company’s relationship with building owners from a one-time hardware transaction to a continuous, data-driven partnership. While currently a small portion of overarching revenue, the connected infrastructure locks customers into the Zurn Elkay ecosystem, ensures timely (and highly profitable) proprietary filter replacements, and creates the foundation for future high-margin software-as-a-service (SaaS) revenue streams.
Judgment:Positive — IoT integration dramatically deepens the economic moat through higher switching costs and guarantees a recurring, high-margin revenue stream via automated filter and parts replacements.
Q10: Is Zurn Elkay’s Low Net Debt Leverage (0.3x) a Prelude to More Aggressive M&A Activity in 2027?
Analysis: Zurn Elkay’s balance sheet is effectively unlevered, presenting a massive strategic advantage. Net debt leverage sits at an astonishing 0.3x, the lowest in the company’s public history. Combined with $365 million in cash, a $540 million untapped revolver, and over $350 million in annual free cash flow, the company is hoarding massive dry powder. While management is currently digesting the $109 million Intellihot acquisition and aggressively repurchasing shares ($100 million YTD), CEO Todd Adams explicitly noted on the Q2 call that the company is preparing for additional adjacency announcements in late 2026 and 2027. This clearly signals that management is actively hunting for larger, transformative acquisitions in the water quality and safety space, preparing to deploy its pristine balance sheet to dramatically expand its TAM once again without stressing solvency.
Judgment:Positive — The fortress balance sheet provides ultimate strategic optionality, practically guaranteeing further high-ROIC M&A expansion without the need for dilutive equity raises or dangerous debt loads.